NCT00402896View on ClinicalTrials.gov

Malignant Pleural Effusion With ZD6474

PHASE2TerminatedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Lung CancerPleural Effusion

Interventions

DRUG

ZD6474

300 mg/day orally for 10 weeks.

Trial Locations (1)

77030

UT MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

United States Department of Defense

FED

collaborator

AstraZeneca

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER